{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:41:19Z","timestamp":1740123679455,"version":"3.37.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2020FYYX017"],"award-info":[{"award-number":["2020FYYX017"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972942"],"award-info":[{"award-number":["81972942"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing Innovative Support Program for Returned Overseas Chinese Scholars","award":["cx2020103"],"award-info":[{"award-number":["cx2020103"]}]},{"name":"High-level Medical Reserved Personnel Training Project of Chongqing","award":["2020GDRC028"],"award-info":[{"award-number":["2020GDRC028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02044-z","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:01:51Z","timestamp":1715587311000},"page":"89-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mass Spectrometry-Based Proteomics Analysis Unveils PTPRS Inhibits Proliferation and Inflammatory Response of Keratinocytes in Psoriasis"],"prefix":"10.1007","volume":"48","author":[{"given":"Xuyu","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"issue":"10275","key":"2044_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/s0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., A. Balato, C. Enerb\u00e4ck, and R. Sabat. 2021. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet (London, England) 397 (10275): 754\u2013766. https:\/\/doi.org\/10.1016\/s0140-6736(21)00184-7.","journal-title":"Lancet (London, England)"},{"issue":"10281","key":"2044_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/s0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C.E.M., A.W. Armstrong, J.E. Gudjonsson, and J. Barker. 2021. Psoriasis. Lancet (London, England) 397 (10281): 1301\u20131315. https:\/\/doi.org\/10.1016\/s0140-6736(20)32549-6.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"2044_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jlb.5mr0120-439r","volume":"108","author":"X Ni","year":"2020","unstructured":"Ni, X., and Y. Lai. 2020. Keratinocyte: A trigger or an executor of psoriasis? Journal of Leukocyte Biology 108 (2): 485\u2013491. https:\/\/doi.org\/10.1002\/jlb.5mr0120-439r.","journal-title":"Journal of Leukocyte Biology"},{"key":"2044_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111574","author":"M Vi\u010di\u0107","year":"2021","unstructured":"Vi\u010di\u0107, M., M. Ka\u0161telan, I. Brajac, V. Soto\u0161ek, and L.P. Massari. 2021. Current concepts of psoriasis immunopathogenesis. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms222111574.","journal-title":"International Journal of Molecular Sciences"},{"issue":"19","key":"2044_CR5","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A.W., and C. Read. 2020. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323 (19): 1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006.","journal-title":"JAMA"},{"key":"2044_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051141","author":"L Chularojanamontri","year":"2019","unstructured":"Chularojanamontri, L., N. Charoenpipatsin, N. Silpa-Archa, C. Wongpraparut, and V. Thongboonkerd. 2019. Proteomics in psoriasis. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms20051141.","journal-title":"International Journal of Molecular Sciences"},{"key":"2044_CR7","doi-asserted-by":"publisher","unstructured":"Lou R, Tang P, Ding K, Li S, Tian C, Li Y, et al. 2020. Hybrid spectral library combining DIA-MS data and a targeted virtual library substantially deepens the proteome coverage. iScience 23(3): 100903. https:\/\/doi.org\/10.1016\/j.isci.2020.100903.","DOI":"10.1016\/j.isci.2020.100903"},{"issue":"6","key":"2044_CR8","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1002\/mas.21781","volume":"42","author":"RB Kitata","year":"2023","unstructured":"Kitata, R.B., J.C. Yang, and Y.J. Chen. 2023. Advances in data-independent acquisition mass spectrometry towards comprehensive digital proteome landscape. Mass Spectrometry Reviews 42 (6): 2324\u20132348. https:\/\/doi.org\/10.1002\/mas.21781.","journal-title":"Mass Spectrometry Reviews"},{"key":"2044_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12014-020-09293-8","volume":"17","author":"Y Li","year":"2020","unstructured":"Li, Y., P. Lin, S. Wang, S. Li, R. Wang, L. Yang, et al. 2020. Quantitative analysis of differentially expressed proteins in psoriasis vulgaris using tandem mass tags and parallel reaction monitoring. Clinical Proteomics 17: 30. https:\/\/doi.org\/10.1186\/s12014-020-09293-8.","journal-title":"Clinical proteomics"},{"issue":"6","key":"2044_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-022-01539-0","volume":"41","author":"DC Mitchell","year":"2023","unstructured":"Mitchell, D.C., M. Kuljanin, J. Li, J.G. Van Vranken, N. Bulloch, D.K. Schweppe, et al. 2023. A proteome-wide atlas of drug mechanism of action. Nature Biotechnology 41 (6): 845\u2013857. https:\/\/doi.org\/10.1038\/s41587-022-01539-0.","journal-title":"Nature Biotechnology"},{"issue":"3","key":"2044_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z., A. Bailey, M.V. Kuleshov, D.J.B. Clarke, J.E. Evangelista, S.L. Jenkins, et al. 2021. Gene set knowledge discovery with enrichr. Current Protocols 1 (3): e90. https:\/\/doi.org\/10.1002\/cpz1.90.","journal-title":"Current protocols"},{"issue":"W1","key":"2044_CR12","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M.V., M.R. Jones, A.D. Rouillard, N.F. Fernandez, Q. Duan, Z. Wang, et al. 2016. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Research 44 (W1): W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377.","journal-title":"Nucleic acids research"},{"key":"2044_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E.Y., C.M. Tan, Y. Kou, Q. Duan, Z. Wang, G.V. Meirelles, et al. 2013. Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14: 128. https:\/\/doi.org\/10.1186\/1471-2105-14-128.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"2044_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson, E.C.B., E.B. Dammer, D.M. Duong, L. Ping, M. Zhou, L. Yin, et al. 2020. Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nature Medicine 26 (5): 769\u2013780. https:\/\/doi.org\/10.1038\/s41591-020-0815-6.","journal-title":"Nature Medicine"},{"issue":"2","key":"2044_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.immuni.2015.07.009","volume":"43","author":"A Bunin","year":"2015","unstructured":"Bunin, A., V. Sisirak, H.S. Ghosh, L.T. Grajkowska, Z.E. Hou, M. Miron, et al. 2015. Protein tyrosine phosphatase PTPRS is an inhibitory receptor on human and murine plasmacytoid dendritic cells. Immunity 43 (2): 277\u2013288. https:\/\/doi.org\/10.1016\/j.immuni.2015.07.009.","journal-title":"Immunity"},{"key":"2044_CR16","doi-asserted-by":"publisher","first-page":"5978271","DOI":"10.1155\/2022\/5978271","volume":"2022","author":"X Zhang","year":"2022","unstructured":"Zhang, X., S. Wang, W. Wang, L. Song, S. Feng, J. Wang, et al. 2022. Extracellular CIRP upregulates proinflammatory cytokine expression via the NF-kappaB and ERK1\/2 signaling pathways in psoriatic keratinocytes. Mediators of Inflammation 2022: 5978271. https:\/\/doi.org\/10.1155\/2022\/5978271.","journal-title":"Mediators of Inflammation"},{"issue":"1","key":"2044_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10238-019-00595-2","volume":"20","author":"GG Teixeira","year":"2020","unstructured":"Teixeira, G.G., N.L. Mari, J.C.C. de Paula, C. Cataldi de Alcantara, T. Flauzino, M.A.B. Lozovoy, et al. 2020. Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis. Clinical and Experimental Medicine 20 (1): 39\u201348. https:\/\/doi.org\/10.1007\/s10238-019-00595-2.","journal-title":"Clinical and Experimental Medicine"},{"issue":"4","key":"2044_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.clindermatol.2011.01.012","volume":"29","author":"L \u010cabrijan","year":"2011","unstructured":"\u010cabrijan, L., and J. Lipozen\u010di\u0107. 2011. Adhesion molecules in keratinocytes. Clinics in Dermatology 29 (4): 427\u2013431. https:\/\/doi.org\/10.1016\/j.clindermatol.2011.01.012.","journal-title":"Clinics in Dermatology"},{"key":"2044_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.688861","author":"MJE Visser","year":"2021","unstructured":"Visser, M.J.E., G. Tarr, and E. Pretorius. 2021. Thrombosis in psoriasis: Cutaneous cytokine production as a potential driving force of haemostatic dysregulation and subsequent cardiovascular risk. Frontiers in Immunology. https:\/\/doi.org\/10.3389\/fimmu.2021.688861.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"2044_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jid.2020.07.028","volume":"141","author":"J Chen","year":"2021","unstructured":"Chen, J., Z. Zhu, Q. Li, Y. Lin, E. Dang, H. Meng, et al. 2021. Neutrophils enhance cutaneous vascular dilation and permeability to aggravate psoriasis by releasing matrix metallopeptidase 9. The Journal of Investigative Dermatology 141 (4): 787\u2013799. https:\/\/doi.org\/10.1016\/j.jid.2020.07.028.","journal-title":"The Journal of Investigative Dermatology"},{"key":"2044_CR21","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.3389\/fimmu.2019.02376","volume":"10","author":"CC Chiang","year":"2019","unstructured":"Chiang, C.C., W.J. Cheng, M. Korinek, C.Y. Lin, and T.L. Hwang. 2019. Neutrophils in psoriasis. Frontiers in Immunology 10: 2376. https:\/\/doi.org\/10.3389\/fimmu.2019.02376.","journal-title":"Frontiers in Immunology"},{"key":"2044_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030619","author":"VV Sobolev","year":"2022","unstructured":"Sobolev, V.V., A.G. Soboleva, E.V. Denisova, E.A. Pechatnikova, E. Dvoryankova, I.M. Korsunskaya, et al. 2022. Proteomic studies of psoriasis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10030619.","journal-title":"Biomedicines"},{"issue":"11","key":"2044_CR23","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/cea.12979","volume":"47","author":"J Wang","year":"2017","unstructured":"Wang, J., M. Su\u00e1rez-Fari\u00f1as, Y. Estrada, M.L. Parker, L. Greenlees, G. Stephens, et al. 2017. Identification of unique proteomic signatures in allergic and non-allergic skin disease. Clinical and Experimental Allergy\u202f: Journal of the British Society for Allergy and Clinical Immunology 47 (11): 1456\u20131467. https:\/\/doi.org\/10.1111\/cea.12979.","journal-title":"Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology"},{"issue":"1","key":"2044_CR24","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1038\/s41598-023-30103-2","volume":"13","author":"NY Kim","year":"2023","unstructured":"Kim, N.Y., J.H. Back, J.H. Shin, M.J. Ji, S.J. Lee, Y.E. Park, et al. 2023. Quantitative proteomic analysis of human serum using tandem mass tags to predict cardiovascular risks in patients with psoriasis. Scientific Reports 13 (1): 2869. https:\/\/doi.org\/10.1038\/s41598-023-30103-2.","journal-title":"Scientific Reports"},{"issue":"9","key":"2044_CR25","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.7150\/thno.31144","volume":"9","author":"M Xu","year":"2019","unstructured":"Xu, M., J. Deng, K. Xu, T. Zhu, L. Han, Y. Yan, et al. 2019. In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine. Theranostics 9 (9): 2475\u20132488. https:\/\/doi.org\/10.7150\/thno.31144.","journal-title":"Theranostics"},{"issue":"2","key":"2044_CR26","doi-asserted-by":"publisher","first-page":"188589","DOI":"10.1016\/j.bbcan.2021.188589","volume":"1876","author":"K Duraivelan","year":"2021","unstructured":"Duraivelan, K., and D. Samanta. 2021. Emerging roles of the nectin family of cell adhesion molecules in tumour-associated pathways. Biochimica et Biophysica Acta Reviews on Cancer 1876 (2): 188589. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188589.","journal-title":"Biochimica et Biophysica Acta Reviews on Cancer"},{"issue":"1","key":"2044_CR27","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1080\/21655979.2021.2021701","volume":"13","author":"B Chen","year":"2022","unstructured":"Chen, B., C. Li, G. Chang, and H. Wang. 2022. Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes. Bioengineered 13 (1): 1530\u20131540. https:\/\/doi.org\/10.1080\/21655979.2021.2021701.","journal-title":"Bioengineered"},{"key":"2044_CR28","doi-asserted-by":"publisher","first-page":"866200","DOI":"10.3389\/fcell.2022.866200","volume":"10","author":"OW Blaschuk","year":"2022","unstructured":"Blaschuk, O.W. 2022. Potential therapeutic applications of N-Cadherin antagonists and agonists. Frontiers in Cell and Developmental Biology 10: 866200. https:\/\/doi.org\/10.3389\/fcell.2022.866200.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"2044_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3892\/ijmm.2020.4771","volume":"47","author":"S Choudhary","year":"2021","unstructured":"Choudhary, S., R. Anand, D. Pradhan, B. Bastia, S.N. Kumar, H. Singh, et al. 2021. Transcriptomic landscaping of core genes and pathways of mild and severe psoriasis vulgaris. International Journal of Molecular Medicine 47 (1): 219\u2013231. https:\/\/doi.org\/10.3892\/ijmm.2020.4771.","journal-title":"International Journal of Molecular Medicine"},{"issue":"1","key":"2044_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/jid.2014.317","volume":"135","author":"NN Mehta","year":"2015","unstructured":"Mehta, N.N., P.K. Dagur, S.M. Rose, H.B. Naik, E. Stansky, J. Doveikis, et al. 2015. IL-17A production in human psoriatic blood and lesions by CD146+ T cells. The Journal of Investigative Dermatology 135 (1): 311\u2013314. https:\/\/doi.org\/10.1038\/jid.2014.317.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"2","key":"2044_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/sj.jid.5700072","volume":"126","author":"A Wetzel","year":"2006","unstructured":"Wetzel, A., T. Wetzig, U.F. Haustein, M. Sticherling, U. Anderegg, J.C. Simon, et al. 2006. Increased neutrophil adherence in psoriasis: Role of the human endothelial cell receptor Thy-1 (CD90). The Journal of Investigative Dermatology 126 (2): 441\u2013452. https:\/\/doi.org\/10.1038\/sj.jid.5700072.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"10","key":"2044_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jdcr.2018.09.009","volume":"4","author":"MS van Kester","year":"2018","unstructured":"van Kester, M.S., S.A.C. Luelmo, M.H. Vermeer, C. Blank, and R. van Doorn. 2018. Remission of psoriasis during treatment with sorafenib. JAAD Case Reports 4 (10): 1065\u20131067. https:\/\/doi.org\/10.1016\/j.jdcr.2018.09.009.","journal-title":"JAAD Case Reports"},{"issue":"2","key":"2044_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5070\/D32Z47H80W","volume":"16","author":"C Fournier","year":"2010","unstructured":"Fournier, C., and G. Tisman. 2010. Sorafenib-associated remission of psoriasis in hypernephroma: Case report. Dermatology Online Journal 16 (2): 17.","journal-title":"Dermatology Online Journal"},{"issue":"5","key":"2044_CR34","first-page":"677","volume":"30","author":"EA Antoniou","year":"2016","unstructured":"Antoniou, E.A., I. Koutsounas, C. Damaskos, and S. Koutsounas. 2016. Remission of psoriasis in a patient with hepatocellular carcinoma treated with sorafenib. In Vivo (Athens, Greece) 30 (5): 677\u2013680.","journal-title":"In Vivo (Athens, Greece)"},{"issue":"5","key":"2044_CR35","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1007\/s10753-021-01477-0","volume":"44","author":"D Xu","year":"2021","unstructured":"Xu, D., and J. Wang. 2021. Downregulation of cathepsin B reduces proliferation and inflammatory response and facilitates differentiation in human HaCaT keratinocytes, ameliorating IL-17A and SAA-induced psoriasis-like lesion. Inflammation 44 (5): 2006\u20132017. https:\/\/doi.org\/10.1007\/s10753-021-01477-0.","journal-title":"Inflammation"},{"issue":"15","key":"2044_CR36","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s40265-019-01205-x","volume":"79","author":"HA Blair","year":"2019","unstructured":"Blair, H.A. 2019. Fedratinib: First approval. Drugs 79 (15): 1719\u20131725. https:\/\/doi.org\/10.1007\/s40265-019-01205-x.","journal-title":"Drugs"},{"issue":"4","key":"2044_CR37","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","volume":"76","author":"W Damsky","year":"2017","unstructured":"Damsky, W., and B.A. King. 2017. JAK inhibitors in dermatology: The promise of a new drug class. Journal of the American Academy of Dermatology 76 (4): 736\u2013744. https:\/\/doi.org\/10.1016\/j.jaad.2016.12.005.","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"2044_CR38","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/bjd.13994","volume":"173","author":"N Punwani","year":"2015","unstructured":"Punwani, N., T. Burn, P. Scherle, R. Flores, J. Shi, P. Collier, et al. 2015. Downmodulation of key inflammatory cell markers with a topical Janus kinase 1\/2 inhibitor. The British Journal of Dermatology 173 (4): 989\u2013997. https:\/\/doi.org\/10.1111\/bjd.13994.","journal-title":"The British Journal of Dermatology"},{"key":"2044_CR39","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.2147\/jir.S356316","volume":"15","author":"J Zhang","year":"2022","unstructured":"Zhang, J., F. Qi, J. Dong, Y. Tan, L. Gao, and F. Liu. 2022. Application of baricitinib in dermatology. Journal of Inflammation Research 15: 1935\u20131941. https:\/\/doi.org\/10.2147\/jir.S356316.","journal-title":"Journal of Inflammation Research"},{"issue":"17","key":"2044_CR40","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1021\/jm200903z","volume":"54","author":"F Liu","year":"2011","unstructured":"Liu, F., D. Barsyte-Lovejoy, A. Allali-Hassani, Y. He, J.M. Herold, X. Chen, et al. 2011. Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines. Journal of Medicinal Chemistry 54 (17): 6139\u20136150. https:\/\/doi.org\/10.1021\/jm200903z.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"9","key":"2044_CR41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41419-023-06134-y","volume":"14","author":"Z Fang","year":"2023","unstructured":"Fang, Z., Y. Wang, B. Huang, X. Chen, R. Jiang, and M. Yin. 2023. Depletion of G9A attenuates imiquimod-induced psoriatic dermatitis via targeting EDAR-NF-\u03baB signaling in keratinocyte. Cell Death & Disease 14 (9): 627. https:\/\/doi.org\/10.1038\/s41419-023-06134-y.","journal-title":"Cell Death & Disease"},{"issue":"6","key":"2044_CR42","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1172\/jci133159","volume":"130","author":"AC Billi","year":"2020","unstructured":"Billi, A.C., J.E. Ludwig, Y. Fritz, R. Rozic, W.R. Swindell, L.C. Tsoi, et al. 2020. KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease. The Journal of Clinical Investigation 130 (6): 3151\u20133157. https:\/\/doi.org\/10.1172\/jci133159.","journal-title":"The Journal of Clinical Investigation"},{"key":"2044_CR43","doi-asserted-by":"publisher","first-page":"659951","DOI":"10.3389\/fcell.2021.659951","volume":"9","author":"F Cornejo","year":"2021","unstructured":"Cornejo, F., B.I. Cort\u00e9s, G.M. Findlay, and G.I. Cancino. 2021. LAR receptor tyrosine phosphatase family in healthy and diseased brain. Frontiers in Cell and Developmental Biology 9: 659951. https:\/\/doi.org\/10.3389\/fcell.2021.659951.","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"2044_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.582220","author":"JY Ren","year":"2020","unstructured":"Ren, J.Y., Y.H. Gu, X.W. Cui, M.M. Long, W. Wang, C.J. Wei, et al. 2020. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in malignant peripheral nerve sheath tumor via profilin 1-induced epithelial-mesenchymal transition 8: 582220. Frontiers in Cell and Developmental Biology.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"2044_CR45","doi-asserted-by":"publisher","first-page":"9296","DOI":"10.1038\/s41598-018-27584-x","volume":"8","author":"TB Davis","year":"2018","unstructured":"Davis, T.B., M. Yang, M.J. Schell, H. Wang, L. Ma, W.J. Pledger, et al. 2018. PTPRS regulates colorectal cancer RAS pathway activity by inactivating erk and preventing its nuclear translocation. Scientific Reports 8 (1): 9296. https:\/\/doi.org\/10.1038\/s41598-018-27584-x.","journal-title":"Scientific Reports"},{"issue":"4","key":"2044_CR46","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/hep.27911","volume":"62","author":"ZC Wang","year":"2015","unstructured":"Wang, Z.C., Q. Gao, J.Y. Shi, W.J. Guo, L.X. Yang, X.Y. Liu, et al. 2015. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition. Hepatology (Baltimore, MD) 62 (4): 1201\u20131214. https:\/\/doi.org\/10.1002\/hep.27911.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"30","key":"2044_CR47","doi-asserted-by":"publisher","first-page":"6700","DOI":"10.1523\/jneurosci.0672-18.2018","volume":"38","author":"KA Han","year":"2018","unstructured":"Han, K.A., J.S. Ko, G. Pramanik, J.Y. Kim, K. Tabuchi, J.W. Um, et al. 2018. PTP\u03c3 drives excitatory presynaptic assembly via various extracellular and intracellular mechanisms. The Journal of Neuroscience\u202f: The Official Journal of the Society for Neuroscience 38 (30): 6700\u20136721. https:\/\/doi.org\/10.1523\/jneurosci.0672-18.2018.","journal-title":"The Journal of Neuroscience : The Official Journal of the Society for Neuroscience"},{"key":"2044_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2017.05.018","volume":"65","author":"Y Ohtake","year":"2017","unstructured":"Ohtake, Y., W. Kong, R. Hussain, M. Horiuchi, M.L. Tremblay, D. Ganea, et al. 2017. Protein tyrosine phosphatase \u03c3 regulates autoimmune encephalomyelitis development. Brain, Behavior, and Immunity 65: 111\u2013124. https:\/\/doi.org\/10.1016\/j.bbi.2017.05.018.","journal-title":"Brain, Behavior, and Immunity"},{"key":"2044_CR49","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.expneurol.2018.01.014","volume":"302","author":"Y Ohtake","year":"2018","unstructured":"Ohtake, Y., A. Saito, and S. Li. 2018. Diverse functions of protein tyrosine phosphatase \u03c3 in the nervous and immune systems. Experimental Neurology 302: 196\u2013204. https:\/\/doi.org\/10.1016\/j.expneurol.2018.01.014.","journal-title":"Experimental Neurology"},{"issue":"2","key":"2044_CR50","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1073\/pnas.1315017111","volume":"111","author":"R Murchie","year":"2014","unstructured":"Murchie, R., C.H. Guo, A. Persaud, A. Muise, and D. Rotin. 2014. Protein tyrosine phosphatase \u03c3 targets apical junction complex proteins in the intestine and regulates epithelial permeability. Proceedings of the National Academy of Sciences of the United States of America 111 (2): 693\u2013698. https:\/\/doi.org\/10.1073\/pnas.1315017111.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"288","key":"2044_CR51","doi-asserted-by":"publisher","first-page":"288ra76","DOI":"10.1126\/scitranslmed.aaa4616","volume":"7","author":"KM Doody","year":"2015","unstructured":"Doody, K.M., S.M. Stanford, C. Sacchetti, M.N. Svensson, C.H. Coles, N. Mitakidis, et al. 2015. Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy. Science Translational Medicine 7 (288): 288ra76. https:\/\/doi.org\/10.1126\/scitranslmed.aaa4616.","journal-title":"Science Translational Medicine"},{"key":"2044_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.82","author":"JE Greb","year":"2016","unstructured":"Greb, J.E., A.M. Goldminz, J.T. Elder, M.G. Lebwohl, D.D. Gladman, J.J. Wu, et al. 2016. Psoriasis. Nature Reviews Disease Primers 2: 10682. https:\/\/doi.org\/10.1038\/nrdp.2016.82.","journal-title":"Nature Reviews Disease Primers"},{"key":"2044_CR53","doi-asserted-by":"publisher","first-page":"788940","DOI":"10.3389\/fimmu.2021.788940","volume":"12","author":"P Hu","year":"2021","unstructured":"Hu, P., M. Wang, H. Gao, A. Zheng, J. Li, D. Mu, et al. 2021. The role of helper T cells in psoriasis. Frontiers in Immunology 12: 788940. https:\/\/doi.org\/10.3389\/fimmu.2021.788940.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"2044_CR54","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes, J.E., T.C. Chan, and J.G. Krueger. 2017. Psoriasis pathogenesis and the development of novel targeted immune therapies. The Journal of Allergy and Clinical Immunology 140 (3): 645\u2013653. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.004.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"2044_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312793","author":"R Singh","year":"2021","unstructured":"Singh, R., S. Koppu, P.O. Perche, and S.R. Feldman. 2021. The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms222312793.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2044_CR56","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/med.21406","volume":"37","author":"MJ Bou-Dargham","year":"2017","unstructured":"Bou-Dargham, M.J., Z.I. Khamis, A.B. Cognetta, and Q.A. Sang. 2017. The role of interleukin-1 in inflammatory and malignant human skin diseases and the rationale for targeting interleukin-1 alpha. Medicinal Research Reviews 37 (1): 180\u2013216. https:\/\/doi.org\/10.1002\/med.21406.","journal-title":"Medicinal Research Reviews"},{"issue":"1","key":"2044_CR57","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","volume":"139","author":"Y Cai","year":"2019","unstructured":"Cai, Y., F. Xue, C. Quan, M. Qu, N. Liu, Y. Zhang, et al. 2019. A critical role of the IL-1\u03b2-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. The Journal of Investigative Dermatology 139 (1): 146\u2013156. https:\/\/doi.org\/10.1016\/j.jid.2018.07.025.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"6","key":"2044_CR58","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes, J.E., B.Y. Yan, T.C. Chan, and J.G. Krueger. 2018. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. Journal of Immunology\u00a0(Baltimore, Md\u202f: 1950) 201 (6): 1605\u20131613. https:\/\/doi.org\/10.4049\/jimmunol.1800013.","journal-title":"Journal of Immunology\u00a0(Baltimore, Md : 1950)"},{"issue":"3","key":"2044_CR59","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1346-8138.14139","volume":"45","author":"E Ogawa","year":"2018","unstructured":"Ogawa, E., Y. Sato, A. Minagawa, and R. Okuyama. 2018. Pathogenesis of psoriasis and development of treatment. The Journal of Dermatology 45 (3): 264\u2013272. https:\/\/doi.org\/10.1111\/1346-8138.14139.","journal-title":"The Journal of Dermatology"},{"issue":"6","key":"2044_CR60","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","volume":"39","author":"HB Schonthaler","year":"2013","unstructured":"Schonthaler, H.B., J. Guinea-Viniegra, S.K. Wculek, I. Ruppen, P. Xim\u00e9nez-Emb\u00fan, A. Gu\u00edo-Carri\u00f3n, et al. 2013. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity 39 (6): 1171\u20131181. https:\/\/doi.org\/10.1016\/j.immuni.2013.11.011.","journal-title":"Immunity"},{"issue":"4","key":"2044_CR61","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.bbrc.2012.05.162","volume":"423","author":"Y Lee","year":"2012","unstructured":"Lee, Y., S. Jang, J.K. Min, K. Lee, K.C. Sohn, J.S. Lim, et al. 2012. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin. Biochemical and Biophysical Research Communications 423 (4): 647\u2013653. https:\/\/doi.org\/10.1016\/j.bbrc.2012.05.162.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2044_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910818","author":"A Kvist-Hansen","year":"2021","unstructured":"Kvist-Hansen, A., H. Kaiser, X. Wang, M. Krakauer, P.M. G\u00f8rtz, B.D. McCauley, et al. 2021. Neutrophil pathways of inflammation characterize the blood transcriptomic signature of patients with psoriasis and cardiovascular disease. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms221910818.","journal-title":"International Journal of Molecular Sciences"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02044-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02044-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02044-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T11:13:29Z","timestamp":1739358809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02044-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["2044"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02044-z","relation":{},"ISSN":["1573-2576"],"issn-type":[{"type":"electronic","value":"1573-2576"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"28 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of the First Affiliated Hospital of Chongqing Medical University (no. 20228201).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board"}},{"value":"Informed consent was obtained from all the participants involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Written informed consent was obtained from the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}